1
|
Culme-Seymour EJ, Mason K, Vallejo-Torres L, Carvalho C, Partington L, Crowley C, Hamilton NJ, Toll EC, Butler CR, Elliott MJ, Birchall MA, Lowdell MW, Mason C. Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series. Tissue Eng Part A 2015; 22:208-13. [PMID: 26559535 DOI: 10.1089/ten.tea.2015.0283] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Stem cell-based tissue-engineered tracheas are at an early stage in their product development cycle. Tens of patients have been treated worldwide in predominantly compassionate use settings, demonstrating significant promise. This potentially life-saving treatment is complex, and the cost and its implications for such treatments are yet to be fully understood. The costs are compounded by varying strategies for graft preparation and transplant, resulting in differing clinical and laboratory costs from different research groups. In this study, we present a detailed breakdown of the clinical and manufacturing costs for three of the United Kingdom (UK) patients treated with such transplants. All three patients were treated under Compassionate Use legislation, within the UK National Health Service (NHS) hospital setting. The total costs for the three UK patients treated ranged from $174,420 to $740,500. All three patients were in a state of poor health at time of treatment and had a number of complexities in addition to the restricted airway. This is the first time a cost analysis has been made for a tissue-engineered organ and provides a benchmark for future studies, as well as comparative data for use in reimbursement considerations.
Collapse
Affiliation(s)
| | - Katrina Mason
- 2 Centre for Cutaneous Research, Blizard Institute of Cell and Molecular Science , London, United Kingdom
| | | | - Carla Carvalho
- 4 Centre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital , London, United Kingdom
| | - Leanne Partington
- 4 Centre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital , London, United Kingdom
| | - Claire Crowley
- 5 Ear Institute, University College London , Royal National Throat Nose and Ear Hospital, London, United Kingdom
| | - Nick J Hamilton
- 5 Ear Institute, University College London , Royal National Throat Nose and Ear Hospital, London, United Kingdom
| | - Ed C Toll
- 6 Great Ormond Street Hospital , Cardiothoracic Surgery, and Tracheal Services, London, United Kingdom
| | - Colin R Butler
- 6 Great Ormond Street Hospital , Cardiothoracic Surgery, and Tracheal Services, London, United Kingdom
| | - Martin J Elliott
- 6 Great Ormond Street Hospital , Cardiothoracic Surgery, and Tracheal Services, London, United Kingdom
| | - Martin A Birchall
- 5 Ear Institute, University College London , Royal National Throat Nose and Ear Hospital, London, United Kingdom
| | - Mark W Lowdell
- 4 Centre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital , London, United Kingdom
| | - Chris Mason
- 7 Advanced Centre for Biochemical Engineering, University College London , London, United Kingdom
| |
Collapse
|